The effect on prognosis of postoperative CA 19-9 level in patients with pancreatic cancer.
Saadettin
S
Kilickap
Cagatay
C
Arslan
D001663:Bilirubin / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D015999:Multivariate Analysis; D018365:Neoplasm, Residual; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D011379:Prognosis; D016016:Proportional Hazards Models; D018714:Radiotherapy, Adjuvant
D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D001663:Bilirubin